Analysts predict that Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) will announce ($0.12) earnings per share (EPS) for the current fiscal quarter, according to Zacks. Zero analysts have made estimates for Acura Pharmaceuticals’ earnings. Acura Pharmaceuticals posted earnings of ($0.19) per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 36.8%. The firm is expected to report its next earnings results on Monday, November 13th.
On average, analysts expect that Acura Pharmaceuticals will report full-year earnings of ($0.46) per share for the current year. For the next fiscal year, analysts expect that the business will report earnings of $0.38 per share. Zacks’ earnings per share calculations are an average based on a survey of sell-side research firms that cover Acura Pharmaceuticals.
Acura Pharmaceuticals (NASDAQ:ACUR) last released its quarterly earnings results on Monday, August 14th. The specialty pharmaceutical company reported ($0.18) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.11) by ($0.07). Acura Pharmaceuticals had a negative net margin of 2,335.87% and a negative return on equity of 1,237.56%. The company had revenue of $0.09 million for the quarter.
TRADEMARK VIOLATION WARNING: This piece was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/2887129/analysts-anticipate-acura-pharmaceuticals-inc-acur-will-announce-earnings-of-0-12-per-share.html.
Acura Pharmaceuticals (NASDAQ:ACUR) traded down 4.62% during mid-day trading on Friday, reaching $0.45. The company’s stock had a trading volume of 22,250 shares. The stock’s market cap is $9.36 million. Acura Pharmaceuticals has a 12-month low of $0.40 and a 12-month high of $1.87. The firm’s 50 day moving average price is $0.46 and its 200 day moving average price is $0.52.
About Acura Pharmaceuticals
Acura Pharmaceuticals, Inc is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication abuse and misuse. The Company has discovered and developed three platform technologies, which can be used to develop multiple products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Acura Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acura Pharmaceuticals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.